DDGP versus SMILE in Newly Diagnosed Advanced Natural Killer/T-Cell Lymphoma: A Randomized Controlled, Multicenter, Open-label Study in China

Li Xin; Cui Yingying; Sun Zhenchang; Zhang Lei; Li Ling; Wang Xinhua; Wu Jingjing; Fu Xiaorui; Ma Wang; Zhang Xudong; Chang Yu; Nan Feifei; Li Wencai; Su Liping; Wang Jinghua; Xue Hongwei; Zhang Mingzhi

首页> 外文期刊>Clinical cancer research: an official journal of the American Association for Cancer Research >DDGP versus SMILE in Newly Diagnosed Advanced Natural Killer/T-Cell Lymphoma: A Randomized Controlled, Multicenter, Open-label Study in China

【24h】

DDGP versus SMILE in Newly Diagnosed Advanced Natural Killer/T-Cell Lymphoma: A Randomized Controlled, Multicenter, Open-label Study in China

机译：DDGP与SMILE在新诊断的晚期自然杀手/ T细胞淋巴瘤中的比较：中国一项随机对照，多中心，开放标签的研究

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose: Optimal treatment strategies for advanced natural killer/T (NK/T)-cell lymphoma have not been fully defined. We compared the safety and efficacy of DDGP and SMILE regimens for advanced NK/T-cell lymphoma in a randomized controlled, multicenter, and open-label clinical trial.

机译：目的：尚未完全确定晚期自然杀伤/ T（NK / T）细胞淋巴瘤的最佳治疗策略。我们在一项随机对照，多中心和开放标签的临床试验中比较了DDGP和SMILE方案治疗晚期NK / T细胞淋巴瘤的安全性和有效性。

著录项

来源
《Clinical cancer research: an official journal of the American Association for Cancer Research 》 |2016年第21期| 共6页
作者
Li Xin; Cui Yingying; Sun Zhenchang; Zhang Lei; Li Ling; Wang Xinhua; Wu Jingjing; Fu Xiaorui; Ma Wang; Zhang Xudong; Chang Yu; Nan Feifei; Li Wencai; Su Liping; Wang Jinghua; Xue Hongwei; Zhang Mingzhi;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学 ;
关键词

相似文献

外文文献
中文文献
专利

1. 中国南方单中心622例成熟T细胞和自然杀伤细胞淋巴瘤患者中CD30在结外鼻型自然杀伤/T细胞淋巴瘤组织中的表达 [J] . Yanfen Feng, Huilan Rao, Yiyan Lei, 癌症（英文版） . 2018 ,第005期
2. DDGP versus SMILE in Newly Diagnosed Advanced Natural Killer/T-Cell Lymphoma: A Randomized Controlled, Multicenter, Open-label Study in China [J] . Li Xin, Cui Yingying, Sun Zhenchang, Clinical cancer research: an official journal of the American Association for Cancer Research . 2016 ,第21期

机译：DDGP与SMILE在新诊断的晚期自然杀手/ T细胞淋巴瘤中的比较：中国一项随机对照，多中心，开放标签的研究
3. Autologous hematopoietic stem cell transplantation may improve long-term outcomes in patients with newly diagnosed extranodal natural killer/T-cell lymphoma, nasal type: a retrospective controlled study in a single center [J] . Wang Jingwen, Wei Liqiang, Ye Jin, International journal of hematology . 2018 ,第1期

机译：自体造血干细胞移植可以改善新诊断患者的外侧天然杀伤/ T细胞淋巴瘤，鼻型的长期结果：在单个中心的回顾性控制研究
4. A phase 2 study of methotrexate, etoposide, dexamethasone, and pegaspargase chemotherapy for newly diagnosed, relapsed, or refractory extranodal natural killer/T‐cell lymphoma, nasal type: a multicenter trial in Northwest China [J] . Liang Rong, Gao Guang‐xun, Chen Jie‐ping, Hematological oncology . 2017 ,第4期

机译：甲氨蝶呤，依托泊苷，地塞米松和Pegaspargase化疗的第2期研究，用于新诊断，复发或难治的外侧自然杀伤/ T细胞淋巴瘤，鼻型：中国西北部的多中心试验
5. An open-label, multicenter, randomized,comparative, safety, efficacy, cycle control,and quality of life study of CTR 25, Alesse ,and Ortho Tri-Cyclen [C] . Victoria Davis, Brian Hauck, Sheila Dunn, World Congress on Fertility and Sterility . 2004

机译：开放标签，多中心，随机，比较，安全，疗效，循环控制和CTR 25，Alesse和Ortho Tri-Cyclen的生命研究
6. Characterization of the Biological and Clinical Relevance of RUNX Genes in Natural Killer/T-Cell Lymphoma [D] . Selvarajan, Viknesvaran 2016

机译：天然杀手/ T细胞淋巴瘤中RUNX基因的生物学和临床意义的表征。
7. Efficacy and safety of cisplatin, dexamethasone, gemcitabine and pegaspargase (DDGP) regimen in newly diagnosed, advanced-stage extranodal natural killer/T-cell lymphoma: interim analysis of a phase 4 study NCT01501149 [O] . Lei Zhang, Sisi Jia, Yangyang Ma, 1967

机译：顺铂，地塞米松，吉西他滨和pegaspargase（DDGP）方案在新诊断的晚期结外自然杀手/ T细胞淋巴瘤中的疗效和安全性：一项4期研究NCT01501149的中期分析
8. A phase 2 study of methotrexate, etoposide, dexamethasone, and pegaspargase chemotherapy for newly diagnosed, relapsed, or refractory extranodal natural killer/T-cell lymphoma, nasal type: a multicenter trial in Northwest China [O] . Rong Liang, Guang-xun Gao, Jie-ping Chen, 2016

机译：用于新诊断，复发或难治的外杀鼠/ T细胞淋巴瘤，鼻腔类型的甲氨蝶呤，依托泊苷，地塞米松和PEGASPARGASE和PEGASPARGASE化学疗法的第2期研究：中国西北部的多中心试验

DDGP versus SMILE in Newly Diagnosed Advanced Natural Killer/T-Cell Lymphoma: A Randomized Controlled, Multicenter, Open-label Study in China

摘要

著录项

相似文献

相关主题

期刊订阅